glp 1 receptor list Table 1 from Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists Understanding GLP-1 receptor agonists and

The weight loss achieved varies by specific medication and dose: semaglutide 2.4 mg (Wegovy) produces approximately 15% weight loss, tirzepatide (Zepbound) up to 15-22%, and liraglutide 3 mg (Saxenda) about 5-8%

Typical 12-month results include 10 to 15% body weight loss (20 to 35 pounds for a 200-pound person), 2 to 4 inch waist circumference reduction, noticeable improvement in body composition especially with exercise, and significant improvement in metabolic markers if they were elevated

Pregnancy and Pre-existing Conditions As with any supplement, those who are pregnant, breastfeeding, or managing a diagnosed medical condition should consult a healthcare professional before starting

Qu hn

Cardiovascular and kidney outcomes GLP-1 medications offer meaningful heart and kidney protection

Calculations are typically based on body weight